Latest Ndis News

Bridge SaaS Limited continues to expand its disability services footprint while developing AI-driven software tools to improve NDIS support delivery, reporting modest positive cash flow and a cash balance of AUD 203,000 at quarter end.

FBR Limited has locked in a binding $400,000–$450,000 Wall as a Service® contract with AMOVEO, marking a key step in deploying its Hadrian® robotic construction technology at scale. The company also inked a strategic MOU to pilot a hybrid robotic-modular housing solution targeting Australia’s affordable housing shortage.

McMillan Shakespeare Limited reported a 9.7% rise in statutory net profit for the first half of FY26, driven by strong revenue growth and productivity gains. The company declared a fully franked 62 cent dividend and announced a $10 million on-market share buyback.

Thrive Tribe Technologies reported a $186,000 net operating cash outflow in Q2 FY26, offset by a $300,000 equity raise to fund growth initiatives and operational expansion.

Bridge SaaS Limited reports steady operational progress in its disability services division, highlighted by the launch of a wholly owned NSW subsidiary and solid cash flow results for the December 2025 quarter.

Mayfield Childcare Limited unveils Mayfield 360, an allied health services division aimed at integrating therapy supports within its childcare network, targeting a sizable and growing segment of the National Disability Insurance Scheme market.

Freedom Care Group Holdings has placed its main operating entity into administration following a sharp decline in cash receipts linked to delayed payments from the NDIA and an ongoing audit. The company’s cash balance dropped significantly, prompting urgent restructuring efforts.

Control Bionics has raised $3.8 million to fuel growth, forged a key distribution deal with Tobii, and integrated with Apple’s BCI protocol, while advancing its NeuroStrip and NeuroBounce platforms.

nib holdings limited signals higher-than-expected non-recurring expenses in the first half of 2026, impacting statutory profit but leaving underlying performance steady.

Control Bionics has integrated Apple’s Brain-Computer Interface protocol into its NeuroNode products, promising simpler setup and enhanced communication for users with severe impairments.

Bridge SaaS Limited reported a robust September quarter, buoyed by its majority-owned Brightside subsidiary's profitability and participant growth, while preparing to launch new NDIS services in New South Wales.

Neurotech International has initiated an Authorised Prescriber program for its lead therapy NTI164, expanding access for children with neurodevelopmental disorders in Australia. The company also secured a Rare Pediatric Disease Designation from the US FDA for NTI164 in Rett Syndrome, marking a key regulatory milestone.